Provided by Tiger Fintech (Singapore) Pte. Ltd.

Progenics Pharmaceuticals

4.10
+0.0000
Volume:- -
Turnover:- -
Market Cap:355.05M
PE:-5.30
High:4.10
Open:4.10
Low:4.10
Close:4.10
Loading ...
Apr 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 15, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 14, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 14, 2020

Major Issues Report

8-K - Current report
Apr 14, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 09, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 02, 2020

Major Issues Report

8-K - Current report
Apr 02, 2020

Business Combinations

Prospectuses and communications, business combinations
Apr 02, 2020

Business Combinations

Prospectuses and communications, business combinations
Apr 01, 2020

Major Issues Report

Current report, item 5.02
Mar 16, 2020

Major Issues Report

8-K - Current report
Mar 13, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2020

Business Combinations

Prospectuses and communications, business combinations
Mar 13, 2020

Major Issues Report

8-K - Current report
Mar 04, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 27, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 26, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 21, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 20, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 20, 2020

Major Issues Report

Current report, items 1.01 and 9.01